Cargando…
Erythropoietin enhances Kupffer cell number and activity in the challenged liver
Erythropoietin (EPO) is the main hormone driving mammalian erythropoiesis, with activity mediated via the surface receptor, EPO-R, on erythroid progenitor cells. Recombinant human EPO is currently used clinically for the treatment of anemia in patients with end-stage renal disease, and in certain ca...
Autores principales: | Gilboa, Dafna, Haim-Ohana, Yasmin, Deshet-Unger, Naamit, Ben-Califa, Nathalie, Hiram-Bab, Sahar, Reuveni, Debby, Zigmond, Ehud, Gassmann, Max, Gabet, Yankel, Varol, Chen, Neumann, Drorit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583293/ https://www.ncbi.nlm.nih.gov/pubmed/28871174 http://dx.doi.org/10.1038/s41598-017-11082-7 |
Ejemplares similares
-
Erythropoietin treatment in murine multiple myeloma: immune gain and bone loss
por: Deshet-Unger, Naamit, et al.
Publicado: (2016) -
Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
por: Kolomansky, Albert, et al.
Publicado: (2020) -
Erythropoietin receptor in B cells plays a role in bone remodeling in mice
por: Deshet-Unger, Naamit, et al.
Publicado: (2020) -
Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone
por: Haim, Yasmin Ohana, et al.
Publicado: (2014) -
Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)